Ferguson Wellman Capital Management Inc. reduced its stake in shares of Monsanto Company (NYSE:MON) by 9.2% during the second quarter, Holdings Channel reports. The institutional investor owned 6,924 shares of the basic materials company’s stock after selling 700 shares during the period. Ferguson Wellman Capital Management Inc.’s holdings in Monsanto were worth $820,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Whitnell & Co. raised its position in Monsanto by 35.4% in the first quarter. Whitnell & Co. now owns 979 shares of the basic materials company’s stock worth $111,000 after buying an additional 256 shares in the last quarter. Hartford Financial Management Inc. acquired a new position in Monsanto during the first quarter worth approximately $113,000. Acrospire Investment Management LLC acquired a new position in Monsanto during the first quarter worth approximately $113,000. JNBA Financial Advisors raised its position in Monsanto by 3.9% in the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock worth $135,000 after buying an additional 45 shares in the last quarter. Finally, Penserra Capital Management LLC raised its position in Monsanto by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,288 shares of the basic materials company’s stock worth $145,000 after buying an additional 112 shares in the last quarter. 75.28% of the stock is currently owned by institutional investors and hedge funds.

Shares of Monsanto Company (MON) opened at 117.14 on Tuesday. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $118.97. The company has a market cap of $51.46 billion, a P/E ratio of 25.30 and a beta of 1.07. The company has a 50-day moving average price of $117.47 and a 200-day moving average price of $115.21.

Monsanto (NYSE:MON) last posted its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The firm had revenue of $4.23 billion during the quarter, compared to analyst estimates of $4.18 billion. During the same period last year, the company posted $2.17 EPS. The business’s quarterly revenue was up 1.0% on a year-over-year basis. On average, analysts predict that Monsanto Company will post $4.89 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be given a $0.54 dividend. This represents a $2.16 annualized dividend and a dividend yield of 1.84%. The ex-dividend date of this dividend is Thursday, October 5th. Monsanto’s dividend payout ratio (DPR) is presently 46.75%.

WARNING: This report was originally reported by Watch List News and is the property of of Watch List News. If you are reading this report on another publication, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this report can be read at https://www.watchlistnews.com/monsanto-company-mon-position-cut-by-ferguson-wellman-capital-management-inc/1488528.html.

A number of equities analysts have commented on MON shares. Royal Bank Of Canada reissued a “sector perform” rating and issued a $128.00 price objective (up previously from $120.00) on shares of Monsanto in a research note on Thursday, June 29th. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price objective on the stock in a research note on Friday, June 16th. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price objective on the stock in a research note on Wednesday, July 12th. Jefferies Group LLC lowered Monsanto from a “buy” rating to a “hold” rating and set a $128.00 price objective on the stock. in a research note on Wednesday, July 12th. Finally, BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a research note on Thursday, June 29th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have issued a buy rating to the company. Monsanto currently has a consensus rating of “Hold” and a consensus target price of $123.15.

In other news, SVP Janet M. Holloway sold 3,337 shares of Monsanto stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $118.00, for a total value of $393,766.00. Following the completion of the transaction, the senior vice president now directly owns 44,405 shares of the company’s stock, valued at approximately $5,239,790. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Janet M. Holloway sold 7,423 shares of Monsanto stock in a transaction dated Tuesday, June 13th. The stock was sold at an average price of $118.00, for a total value of $875,914.00. Following the completion of the transaction, the senior vice president now directly owns 33,645 shares of the company’s stock, valued at $3,970,110. The disclosure for this sale can be found here. Over the last three months, insiders sold 74,470 shares of company stock valued at $8,791,281. Corporate insiders own 0.79% of the company’s stock.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with Analyst Ratings Network's FREE daily email newsletter.